USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
The new ECO grade is made using renewable feedstock
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
PhytoSquene now available for clinical and commercial use
Subscribe To Our Newsletter & Stay Updated